Company: NIVFW
Filing Date: 2025-09-15
Form Type: F-1
Source: 0001213900-25-087717
Chunk: 204

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-15
Form: F-1
Chunk 204
---
     |              |    361,385 |   |     |      |    150,688 |   |
|                                |     |              |  1,512,416 |   |     |      |  1,481,364 |   |
| Less: accumulated depreciation |     |              | (1,239,320 | ) |     |      | (1,319,207 | ) |
| Total                          |     | $            |    273,096 |   |     | $    |    162,157 |   |

Depreciation expenses for
the years ended December 31, 2024 and 2023 were $ and $, respectively.

No impairment loss was recorded for the years
ended December 31, 2024, and 2023.

NOTE 8 — ACCRUED LIABILTIES AND OTHER PAYABLES

Accrued liabilities and other payables consist
of the following:

|                                  |     | December 31, |    2024 |     |   |    2023 |
|:---------------------------------|:----|:-------------|--------:|:----|:--|--------:|
| Accrued expenses                 |     | $            | 201,455 |     | $ |  43,633 |
| Customer deposit                 |     |              |   6,349 |     |   |       - |
| Withholding tax payable          |     |              |   4,361 |     |   |   7,349 |
| Independent director fee payable |     |              |  20,000 |     |   |       - |
| Compensation payable (Note 1)    |     |              | 100,802 |     |   | 144,015 |
| Other payables                   |     |              | 167,762 |     |   |  46,616 |
|                                  |     | $            | 500,729 |     | $ | 241,613 |

F-21

NOTE 9 — CONTRACT LIABILITIES

Contract liabilities consist of the following:

|                                       |     | December 31, |    2024 |   |     |   |       2023 |   |
|:--------------------------------------|:----|:-------------|--------:|:--|:----|:--|-----------:|:--|
| Balance at beginning of year          |     | $            |   7